These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 24577239

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Levels of Endocan, Angiopoietin-2, and Hypoxia-Inducible Factor-1a in Patients with Autosomal Dominant Polycystic Kidney Disease and Different Levels of Renal Function.
    Raptis V, Bakogiannis C, Loutradis C, Boutou AK, Lampropoulou I, Intzevidou E, Sioulis A, Balaskas E, Sarafidis PA.
    Am J Nephrol; 2018; 47(4):231-238. PubMed ID: 29597186
    [Abstract] [Full Text] [Related]

  • 6. Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease.
    Kocyigit I, Yilmaz MI, Orscelik O, Sipahioglu MH, Unal A, Eroglu E, Kalay N, Tokgoz B, Axelsson J, Oymak O.
    Nephron Clin Pract; 2013; 123(3-4):157-64. PubMed ID: 23887359
    [Abstract] [Full Text] [Related]

  • 7. Serum Fas Ligand, Serum Myostatin and Urine TGF-β1 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function.
    Raptis V, Bakogiannis C, Loutradis C, Boutou AK, Sioulis A, Balaskas E, Zebekakis P, Sarafidis PA.
    Kidney Blood Press Res; 2018; 43(3):744-754. PubMed ID: 29794429
    [Abstract] [Full Text] [Related]

  • 8. Serum Copeptin, NLPR3, and suPAR Levels among Patients with Autosomal-Dominant Polycystic Kidney Disease with and without Impaired Renal Function.
    Raptis V, Loutradis C, Boutou AK, Faitatzidou D, Sioulis A, Ferro CJ, Papagianni A, Sarafidis PA.
    Cardiorenal Med; 2020; 10(6):440-451. PubMed ID: 33202410
    [Abstract] [Full Text] [Related]

  • 9. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
    Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, Aydin A, Eyileten T, Ozcan O, Acikel C, Tasar M, Genctoy G, Erbil K, Vural A, Zoccali C.
    Am J Kidney Dis; 2006 Jan; 47(1):42-50. PubMed ID: 16377384
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vascular Dysfunction, Oxidative Stress, and Inflammation in Autosomal Dominant Polycystic Kidney Disease.
    Nowak KL, Wang W, Farmer-Bailey H, Gitomer B, Malaczewski M, Klawitter J, Jovanovich A, Chonchol M.
    Clin J Am Soc Nephrol; 2018 Oct 08; 13(10):1493-1501. PubMed ID: 30228110
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease.
    Sans L, Radosevic A, Quintian C, Montañés R, Gràcia S, Vilaplana C, Mojal S, Ballarin JA, Fernández-Llama P, Torra R, Pascual J.
    PLoS One; 2017 Oct 08; 12(3):e0174583. PubMed ID: 28346513
    [Abstract] [Full Text] [Related]

  • 15. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
    Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, Fukuda S, Wada J, Makino H.
    Nephrol Dial Transplant; 2005 Dec 08; 20(12):2775-82. PubMed ID: 16221689
    [Abstract] [Full Text] [Related]

  • 16. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
    Raina R, Lou L, Berger B, Vogt B, Do AS, Cunningham R, Vasavada P, Herrmann K, Dell K, Simonson M.
    BMC Nephrol; 2016 Feb 29; 17():22. PubMed ID: 26923419
    [Abstract] [Full Text] [Related]

  • 17. Kidney Function Reserve Capacity in Early and Later Stage Autosomal Dominant Polycystic Kidney Disease.
    Messchendorp AL, van Londen M, Taylor JM, de Borst MH, Navis G, Casteleijn NF, Gaillard CAJM, Bakker SJL, Gansevoort RT, DIPAK Consortium.
    Clin J Am Soc Nephrol; 2018 Nov 07; 13(11):1680-1692. PubMed ID: 30254028
    [Abstract] [Full Text] [Related]

  • 18. Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn Study.
    van der Zwan LP, Scheffer PG, Dekker JM, Stehouwer CD, Heine RJ, Teerlink T.
    Clin Sci (Lond); 2011 Jul 07; 121(2):71-8. PubMed ID: 21306304
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Are increased oxidative stress and asymmetric dimethylarginine levels associated with masked hypertension?
    Inan B, Ates I, Ozkayar N, Kundi H, Topcuoglu C, Dede F, Sennaroglu E.
    Clin Exp Hypertens; 2016 Jul 07; 38(3):294-8. PubMed ID: 27018581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.